oxazoles has been researched along with fluorexon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, EF; Barrett, JN; Nonner, D; Panickar, K | 1 |
| Berardi, F; Cantore, M; Colabufo, NA; Contino, M; Inglese, C; Niso, M; Perrone, MG; Perrone, R | 1 |
| Hirt, TD; Litvinchuk, S; Lu, Z; Meier, W; Rigler, P | 1 |
3 other study(ies) available for oxazoles and fluorexon
| Article | Year |
|---|---|
Bone morphogenetic proteins and neurotrophins provide complementary protection of septal cholinergic function during phosphatase inhibitor-induced stress.
Topics: Acetylcholinesterase; Animals; bcl-X Protein; Bone Morphogenetic Proteins; Caspase 3; Caspases; Cell Death; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Embryo, Mammalian; Enzyme Inhibitors; Fluoresceins; Glial Fibrillary Acidic Protein; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Immunohistochemistry; Marine Toxins; Nerve Growth Factors; Nuclear Proteins; Okadaic Acid; Oxazoles; Phosphoric Monoester Hydrolases; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats; Septal Nuclei; Stress, Physiological; tau Proteins; Time Factors; Transfection | 2004 |
Multi-drug-resistance-reverting agents: 2-aryloxazole and 2-arylthiazole derivatives as potent BCRP or MRP1 inhibitors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Dogs; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Kidney; Magnetic Resonance Spectroscopy; Mass Spectrometry; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Oxazoles; Spectrophotometry, Ultraviolet; Thiazoles | 2009 |
Calcein release from polymeric vesicles in blood plasma and PVA hydrogel.
Topics: Animals; Cross-Linking Reagents; Diffusion; Fluoresceins; Hydrogels; Nanocapsules; Oxazoles; Plasma; Polymers; Polyvinyl Alcohol; Solvents; Ultraviolet Rays | 2009 |